FDA Grants Priority Review For Pfizer's Talzenna sNDA For Men With Homologous Recombination Repair Gene-Altered Metastatic Castration-Sensitive Prostate Cancer

Benzinga Newsdesk www.benzinga.com Positive 78.1%

Neg 0% Neu 0% Pos 78.1%

Comments

No comments yet. Be the first!